Our research indicates that GFAP is an exceptionally reliable biomarker for differentiating acute stroke from stroke mimics, demonstrating outstanding sensitivity, perfect specificity, and robust positive and negative predictive values. This evidence concerns the gene GFAP and stroke disorder.